All posts in
UPDATE: Cold Sore Season is Here! AiCuris might have a Herpes Cure
UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa
What’s in the Cards for a Biosimilar after it Launches
Cell Therapies: Is Commercialization holding back a Breakthrough?
Another Brexit Siren Sounds: GSK’s CEO weighs in on the EMA’s (Re)Location
UPDATE: FDA Lifts Hold on Adaptimmune’s Rare Cancer Trials
Evotec chooses Oxford as Proving Ground for Academia-Industry Bridge
UPDATE: The US did the unthinkable. What does this mean for European Biotech?
Next-Gen DNA Sequencers: How low can they go?
Roche hits a Speed Bump on the way to a Hemophilia Cure
NHS adopts Next-Gen Sequencing to Test for Birth Defects
UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug
Labiotech UG, All Rights Reserved -
Send this to friend